Search company, investor...

Dongbao

dongbao.com

About Dongbao

Dongbao is a pharmaceutical company. The company manufactures recombinant biopharmaceuticals, especially recombinant human insulin and Chinese medicine. It is based in Shanghai, Shanghai.

Headquarters Location

93 Huaihai Road Room 1906~1909, Shanghai Times Square

Shanghai, Shanghai, 200021,

China

Missing: Dongbao's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Dongbao's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Dongbao

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Dongbao is included in 1 Expert Collection, including Diabetes.

D

Diabetes

1,898 items

Dongbao Patents

Dongbao has filed 1 patent.

The 3 most popular patent topics include:

  • Experimental cancer drugs
  • Fluoroarenes
  • Protein kinase inhibitors
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/24/2020

Protein kinase inhibitors, Experimental cancer drugs, Receptor tyrosine kinase inhibitors, Tyrosine kinase inhibitors, Fluoroarenes

Application

Application Date

7/24/2020

Grant Date

Title

Related Topics

Protein kinase inhibitors, Experimental cancer drugs, Receptor tyrosine kinase inhibitors, Tyrosine kinase inhibitors, Fluoroarenes

Status

Application

Latest Dongbao News

11:15 EDT Global Smart Insulin or Glucose Responsive Insulin Market (2022 to 2027) - Featuring AstraZeneca, Biocon and Dongbao E...

Aug 16, 2022

News provided by Share this article Share this article The Global Smart Insulin or Glucose Responsive Insulin Market is estimated to be USD 3.12 Bn in 2022 and is expected to reach USD 5.19 Bn by 2027, growing at a CAGR of 10.7%. Market dynamics are forces that impact the prices and behaviors of the Global Smart Insulin or Glucose Responsive Insulin Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks. Company Profiles The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Adocia, AstraZeneca, B. Braun Melsungen, Becton, Dickinson and Company, Biocon, Biodel, Bioton, Dongbao Enterprise Group, Eli Lilly and Company, GSK, etc. Countries Studied America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas) Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe) Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA) Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific) Competitive Quadrant The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc. Ansoff Analysis The report presents a detailed Ansoff matrix analysis for the Global Smart Insulin or Glucose Responsive Insulin Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach. The analyst analyses the using the Ansoff Matrix to provide the best approaches a company can take to improve its market position. Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth. Why buy this report? The report offers a comprehensive evaluation of the Global Smart Insulin or Glucose Responsive Insulin Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies. The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry. The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report. The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies. The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool. Key Topics Covered:

Dongbao Frequently Asked Questions (FAQ)

  • Where is Dongbao's headquarters?

    Dongbao's headquarters is located at 93 Huaihai Road, Shanghai.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.